Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

Overview of attention for article published in The Laryngoscope, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 5 X users
reddit: 1 Redditor

guideline: 1 clinical guideline source

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 10,624 followers.

RT @SydneyVoice: Proud to have been a part of this new publication. Results may provide a strategy for offering systemic bevacizumab for tr…

Proud to have been a part of this new publication. Results may provide a strategy for offering systemic bevacizumab for treatment of recurrent respiratory papillomatosis (RRP). https://t.co/Mp2mqq1cvD #ENT #MedTwitter #MedEd @Sydney_Uni @syd_health @Sta…

RT @SydneyVoice: Recent publication on systemic bevacizumab for treatment of respiratory papillomatosis. What a great list of authors. Well…

RT @SydneyVoice: Check out this new publication which provides a helpful starting point for #clinicians wanting to offer systemic bevacizum…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.